| Financial Year |
March 31 2023 |
| Monetary Funds |
1,217,061,900.06 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
46,964,774.19 |
| Accounts Receivable |
763,776,793.34 |
| Advances to Suppliers |
609,004,880.22 |
| Other Receivables |
38,671,968.24 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,353,570,559.24 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
38,618,827.93 |
| Total Current Assets |
4,293,266,758.59 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
64,507,432.54 |
| Investment Properties |
95,703,122.02 |
| Fixed Assetes |
924,941,884.68 |
| Under-construction Projects |
3,174,399.40 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
174,464,945.87 |
| R&D expenses |
-- |
| Goodwill |
70,955,603.26 |
| Long-Term Deferred and Prepaid Expenses |
4,039,688.15 |
| Deferred Income Tax Assets |
76,095,663.57 |
| Other Non-Current Assets |
43,013,449.98 |
| Sub-Total of Non-Current Assets |
2,068,206,737.82 |
| Total Assets |
6,361,473,496.41 |
| Short-Term Loans |
523,705,416.67 |
| Trading Financial liabilities |
-- |
| Notes Payable |
208,437,646.06 |
| Accounts Payable |
1,388,262,748.49 |
| Accounts Received In Advance |
8,000.00 |
| Employee Compensation Payable |
31,241,739.55 |
| Taxes Payable |
17,749,088.74 |
| Interest Payable |
-- |
| Dividend Payable |
56,487.04 |
| Other payables |
54,647,040.08 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,864,861.86 |
| Other Current Liabilities |
57,517,275.32 |
| Sub-Total of Current Liabilities |
2,810,120,672.93 |
| Long-term Loans |
120,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
82,613,981.19 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
268,827,698.89 |
| Total Liabilities |
3,078,948,371.82 |
| Paid-In Capital(Or Share Stock) |
403,984,805.00 |
| Capital Surplus |
391,690,566.04 |
| Surplus Reserve |
171,291,102.59 |
| LESS:Treasury Stock |
20,654,276.00 |
| Undistributed Profits |
1,101,664,312.11 |
| Minority Stockholder's Interest |
970,262,629.55 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,312,262,495.04 |
| Owner's Equity（Stockholder's Equity） |
3,282,525,124.59 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,361,473,496.41 |
